Correlation Between Genmab AS and Coloplast

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Coloplast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Coloplast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Coloplast AS, you can compare the effects of market volatilities on Genmab AS and Coloplast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Coloplast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Coloplast.

Diversification Opportunities for Genmab AS and Coloplast

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Genmab and Coloplast is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Coloplast AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coloplast AS and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Coloplast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coloplast AS has no effect on the direction of Genmab AS i.e., Genmab AS and Coloplast go up and down completely randomly.

Pair Corralation between Genmab AS and Coloplast

Assuming the 90 days trading horizon Genmab AS is expected to under-perform the Coloplast. In addition to that, Genmab AS is 1.01 times more volatile than Coloplast AS. It trades about -0.2 of its total potential returns per unit of risk. Coloplast AS is currently generating about -0.04 per unit of volatility. If you would invest  93,460  in Coloplast AS on September 3, 2024 and sell it today you would lose (4,520) from holding Coloplast AS or give up 4.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Coloplast AS

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Coloplast AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Coloplast AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Coloplast is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Genmab AS and Coloplast Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Coloplast

The main advantage of trading using opposite Genmab AS and Coloplast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Coloplast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coloplast will offset losses from the drop in Coloplast's long position.
The idea behind Genmab AS and Coloplast AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges